Discovery and Development of Small Molecule Drugs to Enhance Patient Lives

Welcome to Rigel

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders, cancer and rare immune diseases.

Our Pipeline

Our Pipeline

Rigel has a robust and growing pipeline of investigational products focused on treating disease by modulating the immune system.

read more

Clinical Trials

Clinical Trials

Rigel is enrolling a Phase 3 clinical trial for warm antibody Autoimmune Hemolytic Anemia (wAIHA) and a Phase 3 clinical trial for COVID-19.

read more